ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.95
+0.92 (4.18%)
At close: Feb 17, 2026, 4:00 PM EST
23.35
+0.40 (1.74%)
After-hours: Feb 17, 2026, 7:05 PM EST

ACADIA Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,8833,0535,1402,5783,7528,499
Market Cap Growth
24.85%-40.60%99.40%-31.29%-55.85%28.98%
Enterprise Value
3,0912,5374,8522,2043,2787,904
Last Close Price
22.9518.3531.3115.9223.3453.46
PE Ratio
14.8913.48----
Forward PE
33.2035.9027.40---
PS Ratio
3.673.197.084.987.7519.24
PB Ratio
4.234.1711.916.446.9413.56
P/TBV Ratio
4.824.9814.046.446.9413.58
P/FCF Ratio
19.6319.42308.70---
P/OCF Ratio
19.5219.36307.78---
EV/Sales Ratio
2.952.656.684.266.7717.89
EV/EBITDA Ratio
28.5025.33----
EV/EBIT Ratio
32.7430.11----
EV/FCF Ratio
15.6216.14291.36---
Debt / Equity Ratio
0.060.070.130.160.120.08
Debt / EBITDA Ratio
0.450.47----
Debt / FCF Ratio
0.280.333.44---
Net Debt / Equity Ratio
-0.86-0.96-0.88-0.89-0.84-0.93
Net Debt / EBITDA Ratio
-7.30-7.035.631.602.732.52
Net Debt / FCF Ratio
-4.00-4.48-22.923.113.604.05
Asset Turnover
0.910.991.090.800.650.56
Inventory Turnover
9.5313.3318.5351.2229.4435.81
Quick Ratio
2.772.182.133.826.106.44
Current Ratio
3.022.382.424.046.436.77
Return on Equity (ROE)
34.95%38.89%-14.73%-45.89%-28.75%-42.47%
Return on Assets (ROA)
5.11%5.44%-6.86%-21.70%-14.37%-18.66%
Return on Invested Capital (ROIC)
74.54%187.48%-153.38%-343.44%-263.80%-833.48%
Return on Capital Employed (ROCE)
9.70%10.60%-14.80%-48.40%-28.20%-34.60%
Earnings Yield
6.73%7.42%-1.19%-8.38%-4.47%-3.31%
FCF Yield
5.09%5.15%0.32%-4.42%-3.38%-1.69%
Buyback Yield / Dilution
-1.70%-1.55%-1.32%-0.74%-2.01%-6.88%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q